Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)
1,645.00
+15.00 (0.92%)
Apr 28, 2026, 4:55 PM BRT
BCBA:RICH Income Statement
Financials in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 126,726 | 120,754 | 84,989 | 57,518 | 32,366 | Upgrade
|
| Revenue Growth (YoY) | 4.95% | 42.08% | 47.76% | 77.71% | 246.90% | Upgrade
|
| Cost of Revenue | 48,273 | 54,952 | 40,233 | 30,340 | 22,765 | Upgrade
|
| Gross Profit | 78,452 | 65,802 | 44,757 | 27,178 | 9,602 | Upgrade
|
| Selling, General & Admin | 46,832 | 45,903 | 33,217 | 17,935 | 5,110 | Upgrade
|
| Other Operating Expenses | 1,714 | - | - | - | - | Upgrade
|
| Operating Expenses | 48,547 | 45,903 | 33,217 | 17,935 | 5,110 | Upgrade
|
| Operating Income | 29,906 | 19,899 | 11,539 | 9,243 | 4,492 | Upgrade
|
| Interest Expense | -14,967 | -9,012 | -18,718 | -4,456 | -1,451 | Upgrade
|
| Earnings From Equity Investments | -63.36 | -501.85 | -8.39 | 7.33 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -13,054 | -11,485 | -55,069 | -9,159 | -1,783 | Upgrade
|
| Other Non Operating Income (Expenses) | 13,423 | 24,712 | 32,447 | 5,828 | 61.01 | Upgrade
|
| EBT Excluding Unusual Items | 15,245 | 23,612 | -29,808 | 1,462 | 1,319 | Upgrade
|
| Impairment of Goodwill | - | - | -523.72 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -6,911 | 13,984 | 10.26 | 1,019 | 1,436 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 8.19 | 6.46 | Upgrade
|
| Legal Settlements | -229.34 | - | - | - | - | Upgrade
|
| Pretax Income | 8,105 | 37,596 | -30,321 | 2,490 | 2,761 | Upgrade
|
| Income Tax Expense | 5,965 | 6,272 | -6,528 | 1,993 | 1,590 | Upgrade
|
| Earnings From Continuing Operations | 2,140 | 31,324 | -23,794 | 496.36 | 1,172 | Upgrade
|
| Earnings From Discontinued Operations | 683.72 | - | - | - | - | Upgrade
|
| Net Income to Company | 2,823 | 31,324 | -23,794 | 496.36 | 1,172 | Upgrade
|
| Minority Interest in Earnings | 264.58 | 44.33 | 164.53 | 12.58 | -19.42 | Upgrade
|
| Net Income | 3,088 | 31,368 | -23,629 | 508.94 | 1,152 | Upgrade
|
| Net Income to Common | 3,088 | 31,368 | -23,629 | 508.94 | 1,152 | Upgrade
|
| Net Income Growth | -90.16% | - | - | -55.83% | 56.98% | Upgrade
|
| Shares Outstanding (Basic) | 81 | 81 | 81 | 81 | 81 | Upgrade
|
| Shares Outstanding (Diluted) | 81 | 81 | 81 | 81 | 81 | Upgrade
|
| Shares Change (YoY) | -0.00% | 0.00% | -0.04% | 0.06% | -0.00% | Upgrade
|
| EPS (Basic) | 38.24 | 388.45 | -292.62 | 6.30 | 14.27 | Upgrade
|
| EPS (Diluted) | 38.24 | 388.45 | -292.62 | 6.30 | 14.27 | Upgrade
|
| EPS Growth | -90.16% | - | - | -55.85% | 56.99% | Upgrade
|
| Free Cash Flow | -35,921 | 1,181 | -25,022 | -34,174 | -3,045 | Upgrade
|
| Free Cash Flow Per Share | -444.85 | 14.63 | -309.87 | -423.02 | -37.71 | Upgrade
|
| Dividend Per Share | - | 26.890 | - | - | - | Upgrade
|
| Gross Margin | 61.91% | 54.49% | 52.66% | 47.25% | 29.67% | Upgrade
|
| Operating Margin | 23.60% | 16.48% | 13.58% | 16.07% | 13.88% | Upgrade
|
| Profit Margin | 2.44% | 25.98% | -27.80% | 0.89% | 3.56% | Upgrade
|
| Free Cash Flow Margin | -28.34% | 0.98% | -29.44% | -59.41% | -9.41% | Upgrade
|
| EBITDA | 32,999 | 29,469 | 16,621 | 11,522 | 5,165 | Upgrade
|
| EBITDA Margin | 26.04% | 24.40% | 19.56% | 20.03% | 15.96% | Upgrade
|
| D&A For EBITDA | 3,094 | 9,569 | 5,082 | 2,279 | 673.2 | Upgrade
|
| EBIT | 29,906 | 19,899 | 11,539 | 9,243 | 4,492 | Upgrade
|
| EBIT Margin | 23.60% | 16.48% | 13.58% | 16.07% | 13.88% | Upgrade
|
| Effective Tax Rate | 73.60% | 16.68% | - | 80.06% | 57.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.